Advancing cellular pathology and MOHS surgery
Discover how Chukwuyem Usifo, specialist biomedical scientist at Northern Care Alliance NHS Foundation Trust, is driving quality in skin cancer diagnostics for Lab Professionals Week 2026
Discover how Chukwuyem Usifo, specialist biomedical scientist at Northern Care Alliance NHS Foundation Trust, is driving quality in skin cancer diagnostics for Lab Professionals Week 2026
Through a real-world patient story, CLSI explores how laboratory medicine can shape diagnosis and care in complex cases.
The AACR will present the 2026 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research during the AACR Annual Meeting 2026
Celebrate Lab Professionals Week with Daniel Monteiro as he discusses his journey to the bench and the future of the industry
Discover how Dr. Vasiliki E Kalodimou uses advanced flow cytometry to bridge the gap between laboratory precision and personalized biotherapies for Lab Professionals Week 2026
Responses were seen in patients who were not treated with prior KRAS G12C inhibitors as well as those whose disease progressed on prior KRAS G12C inhibitors
Discover how Quadram Institute researcher Dr Amisha Modasia is bridging the gap between dietary fiber and whole body wellness to celebrate Medical Laboratory Professionals Week 2026
An updated trial analysis presented at AACR 2026 showed that the investigational KRAS G12D inhibitor zoldonrasib demonstrated clinical activity with a favorable safety profile in previously treated KRAS G12D‑mutant NSCLC patients
Extended immunotherapy showed manageable long‑term safety in adolescents and young adults with alveolar soft part sarcoma, according to phase II data presented at AACR 2026
The AACR will honor leaders from government and the advocacy community with awards for distinguished service in support of cancer research at the AACR Annual Meeting 2026
Comprehensive analysis of one of the largest datasets with harmonized variant calls from over 8,000 cancer whole genomes enables researchers worldwide to uncover rare drivers, new targets, and AI-ready insights that could reshape precision oncology
At-home self-collection reduces significant barriers for unscreened or under-screened individuals
Expanded antibody portfolio enhances detection of biologics and YTE-modified therapeutics for bioanalytical applications
Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments
Meeting co‑chairs Dr. Paul Mischel and Dr. Alice Shaw share the themes, challenges, and scientific momentum shaping this year’s must‑attend event
Minimally invasive blood test enables greater patient access to monitoring of neuroinflammatory status versus current standard of care methods